Faulty reasoning signals

• Confirmation Bias - 1.5% (2 hits)
• Anchoring Bias - 0%
• Availability Heuristic - 6.7% (9 hits)
• Representativeness Heuristic - 0%
• Hindsight Bias - 0%
• Overconfidence Bias - 0%
• Framing Effect - 17.9% (24 hits)
• Loss Aversion - 0%
• Status Quo Bias - 0%
• Sunk Cost Effect - 0%
• Optimism Bias - 0%
• Pessimism Bias - 0%

Article text

Up and down the ladder: The latest comings and goings

Hired someone new and exciting?

Promoted a rising star?

Finally solved that hard-to-fill spot?

Share the news with us, and we’ll share it with others.

That’s right.

Send us your changes, and we’ll find a home for them.

Don’t be shy.

Everyone wants to know who is coming and going.

And here is our regular feature in which we highlight a different person each week.

This time around, we note that Protillion Biosciences hired Robert Hollingsworth as chief scientific officer.

Previously, he held the same role at Shoreline Therapeutics and, before that, he worked at Pfizer, where he was vice president and chief scientific officer of cancer vaccines and immunotherapeutics.

But all work and no play can make for a dull chief scientific officer.